Effects of okadaic acid and hematein on human lung adenocarcinoma A549 cells and responses of mitochondria and endoplasmic reticulum apoptosis pathways.

BACKGROUND: Okadaic acid (OA) and hematein are both able to inhibit the proliferation of human lung adenocarcinoma A549 cells. However, it is largely unknown about their combined effects on proliferation and apoptosis of A549 cells.
METHODS: The combined effects of the two drugs on proliferation of A549 cells and the responses of mitochondria and endoplasmic reticulum (ER) apoptosis pathways were investigated.
RESULTS: MTT assay showed that both OA and hematein significantly inhibited proliferation of A549 cells, and the combined drugs could further increase the inhibition ratio with lower dosages. Inverted phase contrast microscope and scanning electron microscope (SEM) analysis indicated that the combined drugs aggravated the appearance of apoptotic bodies and damaged cells. Compared to the single drug treated groups, reactive oxygen species (ROS) contents were significantly higher in the groups treated by the combined drugs, and mitochondrial membrane potential was significant lower. Western blot indicated that pro-apoptotic Bax that involved in mitochondrial apoptosis pathway increased, the anti-apoptotic protein Bcl-2 decreased, and the ER apoptosis-related proteins CHOP, Calpain2, JNK1 and IRE1 increased.
CONCLUSIONS: This work demonstrates that OA combined hematein can more effectively inhibit proliferation of A549 cells, and induce apoptosis of A549 cells via mitochondria and ER dependent pathways. 2019 Translational Cancer Research. All rights reserved.

Introduction

At the current stage, more than 1.8 million new lung cancer cases were diagnosed each year (1), and more than one million die of lung cancer each year worldwide. Chemotherapy, radiotherapy and surgery are generally the primary treatments, and can effectively block proliferation of tumor cells, extending patient’s life indefinitely. However, the side effects, such as lusterless complexion, shortness of breath, fatigue, loss of appetite, low white blood cells, easy infection, baldness, severely lower the quality of patient’s life. To reduce the unwanted side effects, increasing attentions have been focused on new anti-cancer medicines.

Cisplatin is currently the most effective drug for non-small cell lung cancer (NSCLC), yet the efficiency of platinum-based chemotherapy is only 30% to 60% (2). Moreover, the harmful side effects make patients suffer from nausea, vomiting, nephrotoxicity, neurotoxicity, and myelosuppression (2). Recently, more and more biological drugs, such as paclitaxel, docetaxel, okadaic acid (OA) and curcumin were used to decrease the side effects of cisplatin by drug combination (3-5). These drugs are closely related to traditional Chinese medicine (TCM), which has been attracting attentions worldwide because of its anticancer effects and low side effects. TCM is a kind of natural medicines, including herbs, animals and mineral. Although TCM hard to effectively inhibit or kill tumour cells as western medicines, a large number of reports suggested that TCM combined other anti-cancer medicines is an efficient method to treat cancer (6,7). To date, grosvenorii, quinquefolium, and tripterygium have been found of strong anti-cancer effects (8-10).

Hematein is an oxidation product of hematoxylin, which can be extracted from haematoxylon campechianum, and has usually been used as an anti-tumor drug, antibacterial drug, and anti-inflammatory drug (11-13). Hematein has been demonstrated able to inhibit proliferation of cancer cells and induce cell apoptosis, such as breast cancer MCF-7 cells and A549 cells (14,15), and has a low toxicity to normal cells, showing a high anti-cancer potential. OA is mainly produced by Prorocentrum lima, is a long-chain fatty acid, and belongs to a diarrhea shellfish toxin. It is a strong carcinogen and poses a serious threat to human health through diet (16). However, increasing research found that OA or combined with other anti-cancer drugs can effectively inhibit rat mesangial cells, human amniotic cells, liver cancer cells, lung cancer cells. Although OA and hematein could inhibit proliferation and induce apoptosis of A549 cells, respectively, their combined effects on proliferation and apoptosis of A549 cells are yet unknown. In this study, MTT assay was employed to investigate the combined effects of OA and hematein on proliferation of A549 cells. Inverted phase contrast microscope, scanning electron microscope (SEM), and western blot were used to reveal the combined effects of OA and hematein on apoptosis of A549 cells. The results benefit exploring new and more effective anti-cancer drugs.

Methods

cells and reagents

A549 cells was purchased from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Beijing, China). OA (C44H68O13) was purchased from Sigma (St. Louis, MO, USA). Hematein (C16H12O6) was purchased from Santacruze (Shanghai, China). RPMI-1640 medium was purchased from Gibco (Grand Island, NY, USA). MTT and DMSO were purchased from Solarbio (Beijing, China). The ECL detection kit was purchased from Pharmacia Biotech (Uppsala, Sweden). The antibody of Bcl-2, Bax and Cytochrome C was purchased from Proteintech (Chicago, USA). The antibody of Chop, Calpain2, JNK1 and IRE1 was purchased from Boaosen Biotechnology Co., Ltd (Beijing, China).

Cell culture

The A549 cells were cultured using RPMI-1640 medium (Gibco BRL, Gaithersburg, MD, USA) supplemented with 100 IU/mL penicillin, 100 µg/mL streptomycin and 10% heat-inactivated newborn fetal calf serum in a CO2 incubator at 37 °C (Sanyo Electronics Co. Ltd., Japan).

Determinations of cell cytotoxicity

Cell cytotoxicity of OA, Hematein and their combination was evaluated by an MTT (Beijing Solarbio Technology Co., Ltd.) assay according to the method described previously (17). The experimental group was divided into blank group, control group, solvent control group and 9 concentration gradient experimental groups. Each group was set with 8 replicates. The cell suspension in logarithmic phase was diluted to 4,000 cells/mL, and then was seeded into a 96-well plate with 100 µL per well. After 24 h cultivation, OA (10–90 ng/mL), hematein (5–100 µg/mL) and hematein (20 µg/mL) combined with OA (10, 20, 40 ng/mL) were added into the wells respectively. After cultivation for 4 h, 20 µL MTT (5 mg/mL) was added into each well, followed by incubation for 4 h. The medium was removed, 150 µL DMSO (Beijing Solarbio Technology Co., Ltd.) was added into each well. The optical density (OD) value was detected at 570 nm in a microplate reader (BIO-RAD, Japan). The group without solvent and drugs was set as blank (B), and group with solvent and drugs was set as solvent control (C) and drug treatment (A) respectively. The entire process was performance in darkness. Cell viability = (A–B)/(C–B) ×100%.

Morphological observation of A549 cells

Inverted phase contrast microscope, fluorescent inverted microscope and SEM were used to detect the morphological changes of A549 cells with or without drugs treatment. For the inverted phase contrast microscope analysis, the cells were treated with the method mentioned above. For fluorescent inverted microscope analysis, acridine orange that can bind to double DNA was added into the treated and untreated A549 cells (104 cells/mL) inoculated in a 6-well plate, and then was set in darkness at room temperature for 0.5 h. Subsequently, the cells were washed 3 times with PBS buffer, and observed under fluorescent inverted microscope (Cairns, Germany). For SEM analysis, the drug treated and untreated cells were harvested and washed 3 times with 0.1M PBS buffer, then, fixed in glutaraldehyde solution at 4 °C for 3 h. After fixation, the samples were washed with PBS, and dehydrated using with different concentrations of ethanol, followed by displacing with isoamyl acetate for 30 min and drying in a dryness oven for 3–4 h. Finally, the cells were visualized under a JSM-6700F SEM (JEOL, Japan).

Detection of mitochondrial depolarization and reactive oxygen species (ROS) levels

JC-1 Mitochondrial Membrane Potential Assay Kit was used to detect mitochondrial depolarization of the drug treated and untreated A549 cells (10 ng/mL OA, 20 µg/mL hematein, and their combination) according to the kit instruction. F-380 fluorescence spectrophotometer (Tianjin Gangdong Technology Development Co., Ltd., China) was used to detect the OD value. The intracellular ROS level was measured by non-fluorescent DCFH-DA (2',7'-dichloro-fluorescein diacetate) oxidation to fluorescent DCF using a ROS assay kit (Beyotime S0033). The fluorescence values were measured in F-380 fluorescence spectrophotometer with excitation wavelength of 488 nm and emission wavelength of 525 nm.

SDS-PAGE and Western blot

Total cell proteins were extracted by conventional methods. The collected proteins (40 µg) was fully denatured by heating at 95–100 °C for 10 min, then were loaded on SDS-PAGE. The proteins were separated by 10% SDS-PAGE and transferred to PVDF membranes (Millipore, Bedford, MA, USA). They were incubated in a blocking solution consisting of 5% skim milk powder in 0.1% Tween-20 PBS (PBS-Tween) overnight with specific antibodies (diluted 1:500 to 10,000). The membrane was then washed at least 3 times and then incubated in PBS-Tween supplemented with a second antibody (containing horseradish peroxidase, diluted 1:5,000) for 2 h. Finally, the membrane was washed again and the protein recognized by the antibody was visualized using the ECL detection kit (Pharmacia Biotech). The drop was placed on the front of the nitrocellulose (NC) filter membrane for about 1 min, placed in an X-ray film holder, and developed and fixed in a dark room.

Statistical analysis

ANOVA based on Duncan’s multiple range test was performed to reveal the differences between the control and drugs treated groups in SPSS 17.0.

Results

Proliferation of A549 cells under drugs treatment

MTT assay showed that both OA and hematein effectively inhibited the proliferation of A549 cells, showing a time-dose dependent manner (). When OA exceeded 30 ng/mL, A549 cells were significantly inhibited, with the inhibition ratio of 78.3% and 86.3% at 48 h and 72 h, respectively, while 50 µg/mL hematein significantly inhibited A549 cells, with the inhibition ratio of 68.5% and 93.4% at 48 h and 72 h, respectively. Compared with single drug treatment, the combined drugs with lower dosage (OA 10 ng/mL and hematein 20 µg/mL) also achieved the same inhibitory effect, with the inhibition ratio up to 73.6% and 94.5% at 48 h and 72 h, respectively. According to Kim’s formula, it suggested that OA and hematein had synergistic inhibitory effects on A549 cell proliferation. Compared to the single drug treated groups (OA 20 ng/mL, hematein 50 µg/mL), 10 ng/mL OA and 20 µg/mL hematein treatment could reach a similar inhibitory ratio.

Figure 1

The inhibitory effects of different concentrations of OA (A) and hematein (B) and their combination (C) on A549 cells. OA, okadaic acid.

Cell morphology

showed that the cell morphology of drug treated A549 cells was significantly changed compared to the control group. The cells were spindle-shaped, and contacted with each other in the control group, whereas, the cells became round or oval (indicated by the arrows), and detached from each other in the drug treated groups. Moreover, more apoptotic bodies (indicated by the arrows) were observed in OA and hematein treated cells than those in the single drug treated groups, indicating cell apoptosis was more obvious. As shown in , the condensed and shattered chromatin (indicated by the arrows) was significantly observed in drug treated groups. SEM analysis indicated () the cell bodies became round accompanied by increased and irregular cell surface protrusions (indicated by the arrows) in the drug treated groups.

Figure 2

The effects of without drugs (a), OA (b) and hematein (c) and their combination (d) on A549 cells observed by inverted phase contrast microscope (A), fluorescent inverted microscope (B) and scanning electron microscope (C). Arrows in A: cells became round or oval; arrows in B: the condensed and shattered chromatin; arrows in C: cell bodies became round accompanied by increased and irregular cell surface protrusions. (A: 40×; B: 40×; C: a, 6000×; b, 4500×; c, 4000×; d, 5000×). OA, okadaic acid.

Mitochondrial depolarization and ROS levels

Apoptosis is frequently associated with depolarization of mitochondrial membrane potential. As showed, JC-1 fluorescence obviously decreased in the OA and hematein treated groups: its red-green fluorescence ratio decreased 0.9 and 0.68 respectively, compared with the control groups. To the groups simultaneously treated by OA and hematein, JC-1 fluorescence decreased 1.73. Compared with the control, the increased OP3 density indicated an increase of ROS levels in the drugs treated group (). Moreover, the ROS level of the combined drugs treated group was significantly higher than that of the control group (P<0.01).

Figure 3

The changes of mitochondrial membrane potential depolarization (A) and intracellular ROS levels (B) with or without drugs treatment. The differences between control and drug treated groups are indicated by asterisks. *, P <0.05; **, P <0.01. OA, okadaic acid; ROS, reactive oxygen species.

The responses of mitochondrial and endoplasmic reticulum (ER) apoptosis-related proteins

Western blot showed that pro-apoptotic Bax protein that relates to mitochondrial apoptotic pathway obviously increased in the drugs treated groups, particularly, the groups treated by drugs combination, and the anti-apoptotic protein Bcl-2 decreased (). The results indicated that mitochondrial apoptotic pathway involved in A549 cell apoptosis induced by the drugs. At the same time, the ER apoptosis-related proteins CHOP, Calpain2, JNK1, and IRE1 significantly increased in the drug treated groups, and the groups treated by drugs combination had the highest protein expression (), indicating that ER apoptotic pathway also played an important role in the drugs induced apoptosis of A549 cells.

Figure 4

Western blot revealed the changes of mitochondrial apoptotic proteins and ER apoptotic proteins of A549 cells with and without drugs treatment. ER, endoplasmic reticulum.

Discussion

Lung cancer has high morbidity and mortality worldwide (18). Although chemotherapy, in particular cisplatin, is one of the most effective treatment for lung cancer (19,20), the side effects on patient’s life quality cannot be ignored. Therefore, increasing efforts have been devoted to the development of new anti-cancer drugs with low toxicity on normal cells (21). Recently, natural anti-cancer medicines have attracted more and more attentions. Some natural medicines, such as grosvenorii, quinquefolium, and garlic, OA, and hematein, were found of strong anti-cancer effects (9,10,22).

This study focused on the combined effects of natural medicines OA and hematein on proliferation and apoptosis of A549 cells. OA is a marine toxin separated from Prorocentrum lima (23), and is of anti-tumor effect at a low dose (24). Recent researches had demonstrated that OA can induce apoptosis of many cell types, including A549 cells, neurotoxicities, human intestinal cell lines, human retinoblastoma Y79 cells (17,25-27). Moreover, it can reduce the side effects of cisplatin, and improve the therapeutic effect on tumors when was combined with cisplatin (28,29). Hematein is an oxidation product of hematoxylin, and was demonstrated able to inhibit cancer cells (11,30). As far as we know, there has no report on the combined effects of OA and hematein on A549 cells.

The results here showed that 30 ng/mL OA and 50 µg/mL hematein could significantly inhibit the proliferation of A549 cells. The proliferation ration is very close to the treatment effect of platinum-based chemotherapy. Importantly, lower dosage (10 ng/mL OA and 20 µg/mL hematein) could achieve the same inhibitory effect when were used in combination. According to Kim's formula, OA and hematein had synergistic inhibitory effects on A549 cell proliferation.

Inducing cell apoptosis is another main pathway of anti-cancer drugs to inhibit proliferation of cancer cells (31). Therefore, cell apoptosis of A549 cells under OA and hematein treatment was investigated. Using inverted phase contrast microscope and SEM, apoptotic bodies and damaged cells were obviously observed under the drugs treated groups, in particular the groups with combined drugs treatment. Mitochondrial apoptosis pathway and ER apoptosis pathway are the key pathways in inducing cell apoptosis. As expected, the intracellular ROS level was significantly elevated and mitochondrial membrane potential decreased in the drugs treated groups. Western blot showed that pro-apoptotic protein Bax increased, while the anti-apoptotic protein Bcl-2 decreased. In addition, the ER apoptosis-related proteins CHOP, Calpain2, JNK1 and IRE1 significantly increased in the drugs treated groups. In addition, it suggested that the drugs combination could aggravate the apoptosis of A549 cells compared with the single drug treated group.

Conclusions

In summary, this study investigated the combined effects of OA and hematein on A549 cells from perspectives of cell proliferation and cell apoptosis. The results demonstrated the higher anti-cancer effects of the drugs combination than the single drug, and revealed that mitochondria and ER apoptosis pathways involved in apoptosis of A549 cells.